Financials
- Market Capitalization 402.54 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.14
市销率
26.03
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3051 | LRMR Larimar Therapeutics, Inc. - Common Stock | 4.01 USD | -0.99% | -2.91% | +5.25% | +2.30% | 416.57 M USD | ||
| 3061 | GALT Galectin Therapeutics Inc. - Common Stock | 4.07 USD | -1.69% | +9.41% | +18.66% | -3.10% | 410.46 M USD | ||
| 3076 | CTNM Contineum Therapeutics, Inc. - Common stock | 17.39 USD | +0.81% | +1.28% | +22.72% | +13.88% | 401.69 M USD | ||
| 3088 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.57 USD | -1.67% | +2.42% | +8.04% | +56.16% | 395.23 M USD |